A mechanism-based pharmacokinetic/pharmacodynamic model allows prediction of antibiotic killing from MIC values for WT and mutants.
about
A multistate tuberculosis pharmacometric model: a framework for studying anti-tubercular drug effects in vitro.Application of the Multistate Tuberculosis Pharmacometric Model in Patients With Rifampicin-Treated Pulmonary TuberculosisA whole-body physiologically based pharmacokinetic (WB-PBPK) model of ciprofloxacin: a step towards predicting bacterial killing at sites of infection.A pharmacokinetic-pharmacodynamic model characterizing the emergence of resistant Escherichia coli subpopulations during ertapenem exposure.Can a pharmacokinetic/pharmacodynamic (PKPD) model be predictive across bacterial densities and strains? External evaluation of a PKPD model describing longitudinal in vitro data.Real-Time Digital Bright Field Technology for Rapid Antibiotic Susceptibility Testing.
P2860
A mechanism-based pharmacokinetic/pharmacodynamic model allows prediction of antibiotic killing from MIC values for WT and mutants.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
A mechanism-based pharmacokine ...... MIC values for WT and mutants.
@en
type
label
A mechanism-based pharmacokine ...... MIC values for WT and mutants.
@en
prefLabel
A mechanism-based pharmacokine ...... MIC values for WT and mutants.
@en
P2093
P2860
P356
P1476
A mechanism-based pharmacokine ...... MIC values for WT and mutants.
@en
P2093
Dan I Andersson
David D Khan
Elisabet I Nielsen
Lena E Friberg
Pernilla Lagerbäck
Ulrika Lustig
P2860
P304
P356
10.1093/JAC/DKV233
P407
P577
2015-09-07T00:00:00Z